Abstract
Tumours are known as wounds that do not heal - this implies that cells that are involved in angiogenesis and the response to injury, such as endothelial cells and fibroblasts, have a prominent role in the progression, growth and spread of cancers. Fibroblasts are associated with cancer cells at all stages of cancer progression, and their structural and functional contributions to this process are beginning to emerge. Their production of growth factors, chemokines and extracellular matrix facilitates the angiogenic recruitment of endothelial cells and pericytes. Fibroblasts are therefore a key determinant in the malignant progression of cancer and represent an important target for cancer therapies.
Keywords
AngiogenesisExtracellular matrixCancerCancer researchCancer cellCancer-Associated FibroblastsChemokineBiologyTumor progressionCell biologyImmunologyMedicineInflammationGenetics
Affiliated Institutions
Related Publications
Tumor Angiogenesis: Therapeutic Implications
THE growth of solid neoplasms is always accompanied by neovascularization. This new capillary growth is even more vigorous and continuous than a similar outgrowth of capillary s...
Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor.
A combination of histological stains has been used to obtain maximum contrast between capillary endothelial cells, fibroblasts, and parenchymal cells in sections of a transplant...
Emerging roles of extracellular vesicles in cellular senescence and aging
Summary Cellular senescence is a cellular program that prevents the proliferation of cells at risk of neoplastic transformation. On the other hand, age‐related accumulation of s...
Chemokines and chemokine receptors: an overview
Chemokines are chemotactic cytokines orchestrating leukocyte recruitment in physiological and pathological conditions. This complex system includes 42 molecules and 19 receptors...
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Therapeutic antibodies that block the programmed death-1 (PD-1)–programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients with various cancer...
Publication Info
- Year
- 2006
- Type
- review
- Volume
- 6
- Issue
- 5
- Pages
- 392-401
- Citations
- 4355
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
4355
OpenAlex
Cite This
Raghu Kalluri,
Michael Zeisberg
(2006).
Fibroblasts in cancer.
Nature reviews. Cancer
, 6
(5)
, 392-401.
https://doi.org/10.1038/nrc1877
Identifiers
- DOI
- 10.1038/nrc1877